A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the maximum tolerated dose, safety and
pharmacokinetics of an investigational drug, intravenous (IV) citrulline, in subjects in
steady-state sickle cell disease.